Journey Medical Corp (DERM) Operating Income (Loss) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Journey Medical Corp quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
  • Journey Medical Corp Operating Income (Loss) for the quarter ending March 31, 2024 was -$10.1 M, a 5.53% decline year-over-year.
  • Journey Medical Corp Operating Income (Loss) for the twelve months ending March 31, 2024 was -$2.6 M, a 92.8% increase year-over-year.
  • Journey Medical Corp annual Operating Income (Loss) for 2023 was -$2.07 M, a 92.5% increase from 2022.
  • Journey Medical Corp annual Operating Income (Loss) for 2022 was -$27.5 M, a 21.1% increase from 2021.
  • Journey Medical Corp annual Operating Income (Loss) for 2021 was -$34.9 M, a 544% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$2.6 M -$10.1 M -$529 K -5.53% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$2.07 M -$2.1 M +$7.89 M +78.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$9.96 M $17.2 M +$26.7 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$36.7 M -$7.65 M -$511 K -7.16% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$36.2 M -$9.56 M -$8.67 M -977% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$27.5 M -$10 M -$938 K -10.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$26.6 M -$9.49 M +$3.15 M +24.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$29.7 M -$7.14 M +$6.62 M +48.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$36.4 M -$888 K -$1.47 M -252% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$34.9 M -$9.06 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$12.6 M -$12.9 M -5391% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$13.8 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $585 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $239 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.